{"id":12391,"date":"2026-11-02T23:22:57","date_gmt":"2026-11-02T20:22:57","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?page_id=12391"},"modified":"2026-11-02T23:22:57","modified_gmt":"2026-11-02T20:22:57","slug":"pilocarpine-uses-interactions-safety","status":"publish","type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=12391","title":{"rendered":"Pilocarpine: Uses, Interactions and Safety"},"content":{"rendered":"

Uses<\/h2>\n

Oral pilocarpine stimulates muscarinic receptors and increases saliva production. It treats dry mouth after head-and-neck radiotherapy and dry mouth associated with Sj\u00f6gren syndrome. Turkish SALAGEN product information also includes Sj\u00f6gren-related dry-eye symptoms. This page covers oral tablets, not eye drops for glaucoma or presbyopia, whose indications and safety details differ.<\/p>\n

Administration<\/h2>\n

Take tablets according to the prescription and the product instructions about meals and fluid. Benefit may need several weeks to be assessed, and ineffective treatment should be reviewed. Avoid adjusting the regimen because sweating or other effects occur; contact the prescriber instead.<\/p>\n

Safety<\/h2>\n

Do not use oral pilocarpine with uncontrolled asthma or when constriction of the pupil is undesirable, such as acute iritis. Product information also restricts use with relevant uncontrolled cardiovascular or kidney disease. Controlled asthma, COPD, important heart disease, gallstones and kidney stones require caution. Excessive sweating can cause dehydration. Blurred vision and difficulty seeing in dim light can make night driving unsafe. Breathing difficulty, fainting or major pulse changes need urgent assessment.<\/p>\n

Interactions<\/h2>\n

Beta-blockers can increase concern about cardiac conduction disturbances, so heart rate and symptoms may need monitoring. Other parasympathomimetic medicines, including cevimeline or pyridostigmine, may add to sweating, gastrointestinal, cardiac and airway effects. Pilocarpine can oppose the desired effects of antimuscarinic treatments. This matters with bladder antimuscarinics and some inhaled medicines; the clinician should review the intended benefit of each drug rather than simply increasing either one. Listed co-use of other medicines in trials does not establish that every combination is risk free.<\/p>\n

Pregnancy and breastfeeding<\/h2>\n

Adequate pregnancy studies are lacking, and animal findings raise concern. Use only when the expected benefit justifies potential risk. Human milk transfer is unknown; discuss whether to continue breastfeeding or treatment.<\/p>\n

Adverse effects<\/h2>\n

Sweating is a major tolerability issue. Flushing, headache, runny nose, nausea, diarrhea and urinary frequency can occur. Report persistent symptoms and signs of dehydration. Do not drive if vision is affected.<\/p>\n

Sources<\/h2>\n